SHOP:NASDAQShopify Inc. Analysis
Data as of 2026-03-14 - not real-time
$122.96
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Shopify (SHOP) is trading at $122.96, well below its 20‑day (≈$123.8), 50‑day (≈$134.9) and 200‑day (≈$140.2) moving averages, signaling a bearish price trend despite a neutral RSI of 45.5 and a bullish MACD histogram. Volume is declining and the 30‑day volatility sits near 75%, while a beta above 2 underscores heightened market sensitivity. Fundamentally, the company posted 30.6% YoY revenue growth to $11.56 B, with solid gross (48%) and operating (20%) margins, but trades at a trailing P/E of 132 versus an industry average of 33 and a DCF‑derived fair value of only $41, indicating pronounced overvaluation.
The recent Q4 2025 earnings missed EPS expectations (reported $0.48 vs $0.51 consensus) and the stock dipped, yet analysts remain optimistic with a median 12‑month target of $160 and a “Buy” consensus. The lack of dividend, high leverage (debt‑to‑equity ≈ 1.4) and a “Greed” sentiment index (72.9) suggest speculative upside, but the valuation gap and technical weakness warrant caution. Investors should weigh the strong growth narrative against the risk of a valuation correction.
The recent Q4 2025 earnings missed EPS expectations (reported $0.48 vs $0.51 consensus) and the stock dipped, yet analysts remain optimistic with a median 12‑month target of $160 and a “Buy” consensus. The lack of dividend, high leverage (debt‑to‑equity ≈ 1.4) and a “Greed” sentiment index (72.9) suggest speculative upside, but the valuation gap and technical weakness warrant caution. Investors should weigh the strong growth narrative against the risk of a valuation correction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below key moving averages and decreasing volume
- Q4 EPS miss and short‑term sentiment shift
- High valuation relative to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained 30% revenue growth and strong operating margins
- Positive MACD histogram indicating potential reversal
- Analyst consensus buy with median target of $160
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Robust platform expansion opportunities and AI‑driven commerce
- Elevated beta and volatility suggesting price swings
- Valuation gap may compress, but growth fundamentals remain solid
Key Metrics & Analysis
Financial Health
Revenue Growth30.60%
Profit Margin10.65%
P/E Ratio132.2
ROE9.84%
ROA8.15%
Debt/Equity1.40
P/B Ratio11.9
Op. Cash Flow$2.0B
Free Cash Flow$1.3B
Industry P/E33.7
Technical Analysis
TrendBearish
RSI45.6
Support$107.43
Resistance$135.96
MA 20$123.82
MA 50$134.91
MA 200$140.23
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value$41.08
Target Price$160.04
Upside/Downside30.16%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.19
Volatility74.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.